RxDoctor Payments DataLook up a doctor →

Mohini Gurme, MD

Clinical Neurophysiology · West Nyack, NYNPI 1316173156

Payments from drug & device makers

$12,972in general payments, 2019–2025

Across 637 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Lilly USA, LLC$677
  • Eisai Inc.$552
  • Novartis$488
  • EMD Serono, Inc.$426
  • SK Life Science, Inc.$425
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)163$3,639
Lilly USA, LLC41$677
Eisai Inc.24$552
Novartis32$488
EMD Serono, Inc.20$426
SK Life Science, Inc.17$425
Kyowa Kirin, Inc.18$371
Amgen17$355
UCB, Inc.17$319
Pfizer18$286
Lundbeck LLC12$286
Sanofi14$284
Adamas Pharmaceuticals, Inc.17$281
Supernus Pharmaceuticals, Inc.17$274
Grifols USA, LLC12$268
Biohaven Pharmaceuticals, Inc.14$233
AstraZeneca(2 entities)11$219
Acadia Pharmaceuticals Inc11$213
Amneal Pharmaceuticals LLC12$210
Biogen10$204
Johnson & Johnson(2 entities)6$202
Genentech USA, Inc.8$189
Argenx US, Inc.6$187
Upsher-smith Laboratories LLC10$171
Sumitomo Pharma America, Inc.7$141
Avanir Pharmaceuticals, Inc.6$141
Tanabe Pharma America, Inc.7$132
Currax Pharmaceuticals LLC9$116
Aucta Pharmaceuticals, Inc.7$109
Assertio Therapeutics, Inc.6$106
Neurelis, Inc.3$106
Arbor Pharmaceuticals, Inc.7$99
CSL Behring4$97
Almatica Pharma LLC3$89
Bristol Myers Squibb5$83
Vertical Pharmaceuticals, LLC4$77
Catalyst Pharmaceuticals, Inc.3$71
Genentech, Inc.1$64
Medtronic3$61
Biohaven Pharmaceutical Holding Company Ltd.3$60
Neurocrine Biosciences, Inc.3$56
Otsuka America Pharmaceutical, Inc.2$52
Sunovion Pharmaceuticals Inc.2$50
Portola Pharmaceuticals, LLC2$49
Impel Pharmaceuticals Inc.2$48
Abbott2$47
Azurity Pharmaceuticals, Inc.2$44
Axsome Therapeutics, Inc.2$43
Aprecia Pharmaceuticals, LLC3$42
Boston Scientific1$29
Teva Pharmaceuticals USA, Inc.2$26
TG Therapeutics, Inc.1$25
Xeris Pharmaceuticals, Inc.1$24
Cala Health, Inc.1$21
Mallinckrodt Hospital Products Inc.1$21
Acorda Therapeutics, Inc1$19
Mallinckrodt Enterprises LLC1$18
Life Molecular Imaging Ltd1$17
Alnylam Pharmaceuticals Inc.1$17
Bausch Health US, LLC1$15

How this compares

$12,972 in reported general payments places this provider in the 85th percentile of 35 clinical neurophysiology providers in New York.

See all clinical neurophysiology providers in New York →

Medicare billing

Part B allowed, 2024
$87,424
Medicare patients
254
Services billed
3,351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical neurophysiology in West Nyack

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →